Regenerative failure in metabolic dysfunction-associated steatohepatitis: The entrapped progenitor model and precision repair
Metabolic dysfunction-associated steatohepatitis (MASH), the progressive inflammatory subtype of metabolic dysfunction-associated steatotic liver disease (MASLD), has emerged as a leading cause of cirrhosis and hepatocellular carcinoma. Despite recent Food and Drug Administration approval of metabolic modulators, l...